Assessing Inequalities In Health & Quality Of Life

Published Apr 17, 2013
Wirral, UK - How should we monitor health disparities across districts? Traditionally, governments measure economic outputs such as gross domestic product (GDP) and health outcomes such as life expectancy. Life expectancy only tells part of the picture; when we adjust life expectancy for health status, the gaps between rich and poor often become even wider. In the study, “Using a Survey to Estimate Health Expectancy and Quality-Adjusted Life Expectancy to Assess Inequalities in Health and Quality of Life,” published in Value in Health, author Brendan Collins, of the University of Liverpool and Wirral Public health, combined health-related quality of life data from a population questionnaire with life expectancy data to estimate quality adjusted life expectancy across a population. This study showed that the gap between rich and poor was much greater when quality of life was included as well as life expectancy. The study revealed a 12.7 year gap in quality adjusted life expectancy between rich and poor in Wirral, an area in the North West of England. The potential value of this gap in quality adjusted life years (QALYs) can be valued in economic terms based on society’s willingness to pay for health interventions. Fiona Johnstone, Wirral’s Director of Policy, Performance & Public Health said, “Combining life expectancy data with quality of life data in this way enables us to understand more about the needs of our population and how individuals in our most deprived areas do not just have shorter life expectancy, but are more likely to experience poor health at every age.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information:

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now